E-LIB Suche - Ergebnisse für: Jänne, P.A.

1

11P Patritumab deruxtecan (HER3-DXd) in previously treated ..:

Hayashi, H. ; Goto, Y. ; Yu, H.A....
ESMO Open. 9 (2024) - p. 102590 , 2024

Link: https://doi.org/10.1016/..

2

267MO Pooled analysis of trastuzumab deruxtecan (T-DXd) ret..:

Rugo, H.S. ; Tokunaga, E. ; Iwata, H....
ESMO Open. 9 (2024) - p. 103326 , 2024

Link: https://doi.org/10.1016/..

3

Antibody–drug conjugates in lung and breast cancer: current..:

Peters, S. ; Loi, S. ; André, F....
Annals of Oncology. 35 (2024) 7 - p. 607-629 , 2024

Link: https://doi.org/10.1016/..

4

16P A phase Ib/II trial to evaluate safety and efficacy of ..:

Le, X. ; Elamin, Y.Y. ; Altan, M....
ESMO Open. 9 (2024) - p. 102595 , 2024

Link: https://doi.org/10.1016/..

5

Translational insights and overall survival in the U31402-A..:

Yu, H.A. ; Baik, C. ; Kim, D.-W....
Annals of Oncology. 35 (2024) 5 - p. 437-447 , 2024

Link: https://doi.org/10.1016/..

6

4O First-line (1L) osimertinib (osi) ± platinum-pemetrexed ..:

Valdiviezo, N. ; Okamoto, I. ; Hughes, B.G.M....
ESMO Open. 9 (2024) - p. 102583 , 2024

Link: https://doi.org/10.1016/..

7

PL03.13 Osimertinib With/Without Platinum-Based Chemotherap..:

Janne, P. ; Planchard, D. ; Cheng, Y....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S36-S37 , 2023

Link: https://doi.org/10.1016/..

8

MA04.03 Osimertinib-induced Epigenetic and Transcriptional ..:

Hartley, A.-V. ; Weston, C. ; Al-Dulaimi, M....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S109-S110 , 2023

Link: https://doi.org/10.1016/..

9

OA05.03 Patritumab Deruxtecan (HER3-DXd) in EGFR-Mutated NS..:

Yu, H.A. ; Goto, Y. ; Hayashi, H....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S53-S54 , 2023

Link: https://doi.org/10.1016/..

10

OA19.05 Activating MET Tyrosine Kinase Domain Mutations as ..:

Nakazawa, S. ; Pecci, F. ; Ricciuti, B....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S88-S89 , 2023

Link: https://doi.org/10.1016/..

11

MA08.11 Initial Chemotherapy for Locally Advanced and Metas..:

Luo, J. ; Finstein, B. ; Sanchez, M....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S128-S129 , 2023

Link: https://doi.org/10.1016/..

12

OA01.07 Sunvozertinib in NSCLC Patients with EGFR Exon20 In..:

Bazhenova, L. ; Chih-Hsin Yang, J. ; Wang, M....
Journal of Thoracic Oncology. 18 (2023) 3 - p. e3 , 2023

Link: https://doi.org/10.1016/..

13

PP01.48 Efficacy and Safety of Patritumab Deruxtecan (HER3-..:

Johnson, M.L. ; Steuer, C.E. ; Hayashi, H....
Journal of Thoracic Oncology. 18 (2023) 3 - p. e30-e31 , 2023

Link: https://doi.org/10.1016/..

14

14MO Updated efficacy and safety of taletrectinib in patien..:

Li, W. ; Yang, N. ; Li, K....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S47-S48 , 2023

Link: https://doi.org/10.1016/..

15

Molecular markers of metastatic disease in KRAS-mutant lung..:

Boiarsky, D. ; Lydon, C.A. ; Chambers, E.S....
Annals of Oncology. 34 (2023) 7 - p. 589-604 , 2023

Link: https://doi.org/10.1016/..